Đang chuẩn bị liên kết để tải về tài liệu:
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

The main reason for treatment failure after curative surgical resection of gastric cancer is intraabdominal spread, with 40–50% peritoneal seeding as primary localization of recurrence. Peritoneal relapse is seen in 60–70% of tumors of diffuse type, compared to only 20–30% of intestinal type. |